Metabolomic Variations in the Saxagliptin-Treated Type 2 Diabetes Mellitus Patients

NCT01768208 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

569

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Saxagliptin

Sponsor

Shanghai Jiao Tong University School of Medicine